Global Infertility Diagnosis and Treatment Market Is Likely to Experience a Tremendous Growth by 2028

The global infertility diagnosis and treatment market is anticipated to grow at a CAGR of 7.0% during the forecast period. Lifestyle factors such as smoking, stress, weight, and also the female age factor (age above 35 years) are the reason behind infertility. The major factor driving the growth of the global infertility diagnosis and treatment market during the forecast period is the increasing infertility rate across the globe. According to the Centers for Disease Control and Prevention (CDC), among heterosexual women aged 15 to 49 years with no prior births, about 1 in 5, or 19% are unable to get pregnant after one year of trying due to infertility. Additionally, about 1 in 4 or 26% of women in this group have difficulty getting pregnant or carrying a pregnancy to term due to impaired fecundity. Moreover, infertility and impaired fecundity are less common among women with one or more prior births. Furthermore, in this group, about 6% of married women aged 15 to 49 years are unable to get pregnant after one year of trying and 14% have difficulty getting pregnant or carrying a pregnancy to term. Hence, this is driving the demand for diagnosis and treatment of infertility which in turn is driving the growth of the market.

Get Free Sample link @ https://www.omrglobal.com/request-sample/infertility-diagnosis-and-treatment-market-analysis

During COVID-19, many countries had been impacted by the pandemic, and the governments of these countries had ordered nationwide lockdowns which shut down operations of various industries. Additionally, the COVID-19 pandemic presented various challenges to clinical healthcare providers and patients such as managing patients with the disease, prioritizing patients with comorbidities and pre-existing conditions as well as protecting the public and hospital frontline workers from exposure to the COVID-19 infection across the globe. Furthermore, the market was also affected due to a significant drop in the number of patients undergoing infertility diagnosis and treatment during the COVID-19 pandemic.

A full report of Global Infertility Diagnosis and Treatment Market available @ https://www.omrglobal.com/industry-reports/infertility-diagnosis-and-treatment-market-analysis

  • Market Coverage
  • Market number available for – 2022-2028
  • Base year- 2021
  • Forecast period- 2022-2028
  • Segment Covered- By Source, By Product Type, By Applications
  • Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others

Market Segmentation

Global Infertility Diagnosis and Treatment Market by Diagnosis

  • Male Infertility Diagnosis
  • .Semen Analysis
  • Genetic Testing
  • Testicular Biopsy
  • Hormone Testing
  • Others
  • Female Infertility Diagnosis
  • Ovulation Testing
  • Hysterosalpingography
  • Hysteroscopy
  • Imaging Testing
  • Ovarian Reserve Testing
  • Hormonal Level Testing
  • Genetic Testing
  • Others

Global Infertility Diagnosis and Treatment Market by Infertility Treatment

  • Male Infertility Treatment
  • .Drugs and Medicine
  • Surgical
  • Assisted Reproductive Technology (ART)
  • Others
  • Female Infertility Treatment
  • .Drugs and Medicine
  • Surgical
  • Intrauterine Insemination (IUI)
  • Assisted Reproductive Technology (ART)
  • In-Vitro Fertilization (IVF)
  • Intracytoplasmic Sperm Injection (ICSI)
  • Assisted Hatching
  • Others

Regional Analysis

  • North America
  • United States
  • Canada
  • Europe
  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
  • Rest of the World

Company Profiles 

  • Bayer AG
  • Bristol-Myers Squibb Co.
  • Church & Dwight Co. Inc.
  • Cook Medical, Inc.
  • Coopersurgical Inc.
  • Eli Lilly & Co.
  • EMD Serono, Inc
  • Endo Pharmaceuticals Inc.
  • Ferring Pharmaceuticals
  • Genea
  • Glaxosmithkline Plc
  • Halotech Dna
  • .Irvine Scientific
  • Janssen Pharmaceutical
  • Novartis International Ag
  • Origio
  • Ovascience
  • Pfizer Inc.
  • Princeton Biomeditech Corp.
  • Progyny
  • Quidel Corp
  • Vitrolife Ab
  • Vivus Inc.

The Report Covers

  • Market value data analysis of 2021 and forecast to 2028.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global infertility diagnosis and treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/infertility-diagnosis-and-treatment-market-analysis

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 780-304-0404